Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Mar;73(5):560–564. doi: 10.1038/bjc.1996.98

Preclinical in vivo efficacy of two 9-dihydrotaxane analogues against human and murine tumours.

J D Alder 1, K P Jarvis 1, K C Marsh 1, L L Klein 1, J J Clement 1
PMCID: PMC2074348  PMID: 8605087

Abstract

Two 9-dihydrotaxane analogues were synthesised and tested for in vitro potency and in vivo efficacy against murine and human tumour xenografts in mice. The in vitro potency of 9-dihydrotaxol (9-DH-t) and 10-deacetyl-9-dihydrotaxol (10-DeAc-9-DH-t) was generally less than that of paclitaxel against human and murine tumour cells. However, both analogues were at least 20-fold more soluble than paclitaxel in water. The analogues yielded cure rates > or = 60% against human MX-1 solid tumour xenografts in mice, compared with a cure rate of 10% for mice treated with paclitaxel. Both of the analogues were more effective than paclitaxel for treatment of murine M109 solid tumour in mice. 10-DeAc-9-DH-t was as effective as paclitaxel against murine B16 ascites tumour, while 9-DH-t was less effective. Both 10-DeAc-9-DH-t and 9-DH-t were demonstrably less toxic than paclitaxel. At equal dosages 9-DH-t produced serum concentrations greater than paclitaxel, while 10-DeAc-9-DH-t yielded serum concentrations less than paclitaxel. However, the decrease in toxicity of 9-DH-t and 10-DeAc-9-DH-t allowed a 4-fold increase in daily dosage. These two 9-dihydrotaxane analogues yielded favourable preclinical data and demonstrated good potential for further development.

Full text

PDF
560

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bissery M. C., Guénard D., Guéritte-Voegelein F., Lavelle F. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res. 1991 Sep 15;51(18):4845–4852. [PubMed] [Google Scholar]
  2. Chu D. T., Hallas R., Clement J. J., Alder J., McDonald E., Plattner J. J. Synthesis and antitumour activities of quinolone antineoplastic agents. Drugs Exp Clin Res. 1992;18(7):275–282. [PubMed] [Google Scholar]
  3. Fuchs D. A., Johnson R. K. Cytologic evidence that taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poison. Cancer Treat Rep. 1978 Aug;62(8):1219–1222. [PubMed] [Google Scholar]
  4. Li L., Thomas S. A., Klein L. L., Yeung C. M., Maring C. J., Grampovnik D. J., Lartey P. A., Plattner J. J. Synthesis and biological evaluation of C-3'-modified analogs of 9(R)-dihydrotaxol. J Med Chem. 1994 Aug 19;37(17):2655–2663. doi: 10.1021/jm00043a005. [DOI] [PubMed] [Google Scholar]
  5. McGuire W. P., Rowinsky E. K., Rosenshein N. B., Grumbine F. C., Ettinger D. S., Armstrong D. K., Donehower R. C. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med. 1989 Aug 15;111(4):273–279. doi: 10.7326/0003-4819-111-4-273. [DOI] [PubMed] [Google Scholar]
  6. Ringel I., Horwitz S. B. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst. 1991 Feb 20;83(4):288–291. doi: 10.1093/jnci/83.4.288. [DOI] [PubMed] [Google Scholar]
  7. Rose W. C. Evaluation of Madison 109 lung carcinoma as a model for screening antitumor drugs. Cancer Treat Rep. 1981 Mar-Apr;65(3-4):299–312. [PubMed] [Google Scholar]
  8. Rose W. C. Taxol: a review of its preclinical in vivo antitumor activity. Anticancer Drugs. 1992 Aug;3(4):311–321. [PubMed] [Google Scholar]
  9. Rowinsky E. K., Burke P. J., Karp J. E., Tucker R. W., Ettinger D. S., Donehower R. C. Phase I and pharmacodynamic study of taxol in refractory acute leukemias. Cancer Res. 1989 Aug 15;49(16):4640–4647. [PubMed] [Google Scholar]
  10. Schiff P. B., Fant J., Horwitz S. B. Promotion of microtubule assembly in vitro by taxol. Nature. 1979 Feb 22;277(5698):665–667. doi: 10.1038/277665a0. [DOI] [PubMed] [Google Scholar]
  11. Schiff P. B., Horwitz S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1561–1565. doi: 10.1073/pnas.77.3.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wani M. C., Taylor H. L., Wall M. E., Coggon P., McPhail A. T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc. 1971 May 5;93(9):2325–2327. doi: 10.1021/ja00738a045. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES